Abstract

Humans are continuously exposed to airborne spores of the saprophytic fungus Aspergillus fumigatus. However, in healthy individuals pulmonary host defense mechanisms efficiently eliminate the fungus. In contrast, A. fumigatus causes devastating infections in immunocompromised patients. Host immune responses against A. fumigatus lung infections in immunocompromised conditions have remained largely elusive. Given the dynamic changes in immune cell subsets within tissues upon immunosuppressive therapy, we dissected the spatiotemporal pulmonary immune response after A. fumigatus infection to reveal basic immunological events that fail to effectively control invasive fungal disease. In different immunocompromised murine models, myeloid, notably neutrophils, and macrophages, but not lymphoid cells were strongly recruited to the lungs upon infection. Other myeloid cells, particularly dendritic cells and monocytes, were only recruited to lungs of corticosteroid treated mice, which developed a strong pulmonary inflammation after infection. Lymphoid cells, particularly CD4+ or CD8+ T-cells and NK cells were highly reduced upon immunosuppression and not recruited after A. fumigatus infection. Moreover, adoptive CD11b+ myeloid cell transfer rescued cyclophosphamide immunosuppressed mice from lethal A. fumigatus infection but not cortisone and cyclophosphamide immunosuppressed mice. Our findings illustrate that CD11b+ myeloid cells are critical for anti-A. fumigatus defense under cyclophosphamide immunosuppressed conditions.

Highlights

  • Respiratory lung infections caused by the pathogenic mold Aspergillus fumigatus result in life-threatening complications in immunocompromised patients, for instance, after allogeneic hematopoietic cell transplantation, solid organ transplantation, chemotherapy for cancer, or other acquired or congenital immune disorders (Nihtinen et al, 2010; Kousha et al, 2011; Aspergillus fumigatus and Immune ResponseSingh et al, 2013)

  • A compromised immune system provide the basis for germination of A. fumigatus conidia and subsequent lung infections (Margalit and Kavanagh, 2015)

  • Most of the in vivo studies focused on depleting a defined immune cell population from healthy murine models to determine the consequences of loss of distinct cell populations on survival and overall outcome of the disease

Read more

Summary

Introduction

Respiratory lung infections caused by the pathogenic mold Aspergillus fumigatus result in life-threatening complications in immunocompromised patients, for instance, after allogeneic hematopoietic cell transplantation, solid organ transplantation, chemotherapy for cancer, or other acquired or congenital immune disorders (Nihtinen et al, 2010; Kousha et al, 2011; Aspergillus fumigatus and Immune ResponseSingh et al, 2013). The conidia are rapidly released into the environment Their hydrophobic exterior and small diameter of 2–3 μm facilitates them to reach the lung alveoli by crossing physiological barriers (Latge, 1999; Dagenais and Keller, 2009; Park and Mehrad, 2009). It appears essential to develop therapies that improve the host immune defense in immunocompromised patients. To this end, an indepth understanding of the dynamic host immune responses against A. fumigatus lung infections under immunocompromised condition is a prerequisite for successful applications of novel therapeutic strategies to effectively manage and treat lung infections in high-risk immunocompromised patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call